BLTE BELITE BIO, INC Insider Trading

CFO Chuang Hao-Yuan sold 6,200 shares ($1.1M) at $181.50 avg; post-sale holding: 93,800 shares (93.8K).

Chuang Hao-Yuan, Chief Financial Officer at BELITE BIO, INC, executed 4 separate sales totaling 6,200 shares for $1,125,303.44 on 2026-04-09, at prices ranging from $180.35 to $183.08, with a blended average price of $181.50. The sale reduced his holdings from 100,000 shares to 93,800 shares, representing a -6.2% reduction in position size. This transaction occurred with the stock trading at $173.18 currently, 9.0% below its 52-week high of $190.30, and the insider sold at prices ($180.35–$183.08) above the current market level, during a period when the stock has risen 5.5% over the prior 30 days and 10.3% over 90 days. The CFO retained 93.8K shares post-transaction, maintaining a material stake in the company.

CEO Lin Yu-Hsin sold 9,200 shares for $1,669,338.90 across 4 transactions on 2026-04-09 at blended avg $181.45

Lin Yu-Hsin, BELITE BIO's Chief Executive Officer, executed 4 separate sales totaling 9,200 shares for $1,669,338.90 on 2026-04-09, reducing his holdings from 180,134 shares to 170,934 shares (a 5.1% reduction). The sales occurred at prices ranging from $180.36 to $183.00, with a blended average of $181.45, which was within 4.7% of the current price of $173.18. The current stock price sits 9.0% below its 52-week high of $190.30, suggesting the sales occurred near recent peaks in the trading range.